Cargando…
Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
An increasing amount of evidence suggests that high‐density lipoprotein cholesterol (HDL‐C) is related to a positive prognosis in various cancers. However, the correlation between HDL‐C and the immune signature and the prognostic role of HDL‐C in stage II/III colorectal cancer (CRC) has not been pre...
Autores principales: | Wang, Yun, Sun, Xiao‐qiang, Lin, Hao‐cheng, Wang, De‐shen, Wang, Zhi‐qiang, Shao, Qiong, Wang, Feng‐hua, Yan, Shu‐mei, Liang, Jie‐ying, Zeng, Zhao‐lei, Ju, Huai‐qiang, Xu, Rui‐hua, Li, Yu‐hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434197/ https://www.ncbi.nlm.nih.gov/pubmed/30729718 http://dx.doi.org/10.1002/cam4.1987 |
Ejemplares similares
-
Reduced serum high-density lipoprotein cholesterol levels and aberrantly expressed cholesterol metabolism genes in colorectal cancer
por: Tao, Jin-Hua, et al.
Publicado: (2022) -
Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
por: Wang, Yun, et al.
Publicado: (2016) -
Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019) -
Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020) -
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)